Sun Pharmaceutical Industries Ltd.

SUNPHARMA

₹1846.05

0.55% (10.05)

Market Cap

₹4,43,025 Cr.

P/E

42.64

About

Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, known for delivering high-quality products at affordable prices. With a diverse portfolio covering… Read more

Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in… Read more

Low

1068

52W Range

High

1873

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

6.42 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.13 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.01 %

(as of Feb 20)

Historic

Anti-Malarial - Market Share

2.43 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

3.41 %

(as of Nov 21)

Historic

Blood Related - Market Share

6.88 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.19 %

(as of Nov 21)

Historic

Dermatology - Market Share

6.24 %

(as of Nov 21)

Historic

Endocrinology - Market Share

7.45 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

5.97 %

(as of Nov 21)

Historic

Gynecology - Market Share

22.70 %

(as of Nov 21)

Historic

Neurological - Market Share

13.47 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

2.98 %

(as of Nov 21)

Historic

Pain - Market Share

7.70 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

3.63 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.75 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

3.62 %

(as of Nov 21)

Historic

Urology - Market Share

1.91 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

US DMF Filings (.)
Source
US DMF Approval (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Garlic Pearls

Revital

Volini

Suppliers

Bharat Dynamics Ltd.
Laurus Labs Ltd.
Aarti Industries Ltd.
Navin Fluorine International Ltd.
Shakti Pumps (India) Ltd.
Balaji Amines Ltd.
Borosil Renewables Ltd.
GMM Pfaudler Ltd.
AGI Greenpac Ltd.
Aarti Drugs Ltd.
Shaily Engineering Plastics Ltd.
TCPL Packaging Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
HLE Glascoat Ltd.
B.L. Kashyap and Sons Ltd.
Gulshan Polyols Ltd.
Control Print Ltd.
Bliss GVS Pharma Ltd.
Bharat Parenterals Ltd.
Mold-Tek Technologies Ltd.
Empire Industries Ltd.
Zenotech Laboratories Ltd.
Zim Laboratories Ltd.
Inspirisys Solutions Ltd.
Hindusthan National Glass & Industries Ltd.
Jocil Ltd.

Showing 5 of 26

FAQs on Sun Pharmaceutical Industries Ltd. Business

What does Sun Pharma Inds. do?

Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, offering a wide range of high-quality and affordable products globally.

Who are the competitors of Sun Pharma Inds.?

Sun Pharma Inds. major competitors are Cipla, Torrent Pharma, Zydus Lifesciences, Dr. Reddy's Lab, Lupin, Mankind Pharma, Aurobindo Pharma.
Market Cap of Sun Pharma Inds. is ₹4,46,984 Crs.
While the median market cap of its peers are ₹1,10,939 Crs.

Is Sun Pharma Inds. financially stable compared to its competitors?

Sun Pharma Inds. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Sep			Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec